Propranolol	B:C0033497
Effects	O
on	O
Decompression	O
Sickness	I:C0011119
in	O
a	O
Simulated	O
DISSUB	O
Rescue	O
in	O
Swine	O
.	O

Propranolol	O
Effects	O
on	O
Decompression	B:C0011119
Sickness	I:C0011119
in	O
a	O
Simulated	O
DISSUB	O
Rescue	O
in	O
Swine	O
.	O

Propranolol	O
Effects	O
on	O
Decompression	O
Sickness	I:C0011119
in	O
a	O
Simulated	O
DISSUB	O
Rescue	O
in	O
Swine	B:C1135183
.	O

Disabled	O
submarine	O
(	O
DISSUB	O
)	O
survivors	O
may	O
face	O
elevated	B:C0020440
CO2	I:C0020440
levels	I:C0020440
and	O
inert	O
gas	O
saturation	O
,	O
putting	O
them	O
at	O
risk	O
for	O
CO2	O
toxicity	O
and	O
decompression	O
sickness	I:C0011119
(	O
decompression	O
sickness	I:C0011119
)	O
.	O

Disabled	O
submarine	O
(	O
DISSUB	O
)	O
survivors	O
may	O
face	O
elevated	O
CO2	I:C0020440
levels	I:C0020440
and	O
inert	O
gas	O
saturation	O
,	O
putting	O
them	O
at	O
risk	O
for	O
CO2	B:C0007012
toxicity	O
and	O
decompression	O
sickness	I:C0011119
(	O
decompression	O
sickness	I:C0011119
)	O
.	O

Disabled	O
submarine	O
(	O
DISSUB	O
)	O
survivors	O
may	O
face	O
elevated	O
CO2	I:C0020440
levels	I:C0020440
and	O
inert	O
gas	O
saturation	O
,	O
putting	O
them	O
at	O
risk	O
for	O
CO2	O
toxicity	O
and	O
decompression	B:C0011119
sickness	I:C0011119
(	O
decompression	O
sickness	I:C0011119
)	O
.	O

Disabled	O
submarine	O
(	O
DISSUB	O
)	O
survivors	O
may	O
face	O
elevated	O
CO2	I:C0020440
levels	I:C0020440
and	O
inert	O
gas	O
saturation	O
,	O
putting	O
them	O
at	O
risk	O
for	O
CO2	O
toxicity	O
and	O
decompression	O
sickness	I:C0011119
(	O
decompression	B:C0011119
sickness	I:C0011119
)	O
.	O

Propranolol	B:C0033497
was	O
shown	O
to	O
reduce	O
CO2	I:C0201930
production	I:C0201930
in	O
an	O
experimental	O
DISSUB	O
model	O
in	O
humans	O
but	O
its	O
effects	O
on	O
decompression	O
sickness	I:C0011119
in	O
a	O
DISSUB	O
rescue	O
scenario	O
are	O
unknown	O
.	O

Propranolol	O
was	O
shown	O
to	O
reduce	B:C0201930
CO2	I:C0201930
production	I:C0201930
in	O
an	O
experimental	O
DISSUB	O
model	O
in	O
humans	O
but	O
its	O
effects	O
on	O
decompression	O
sickness	I:C0011119
in	O
a	O
DISSUB	O
rescue	O
scenario	O
are	O
unknown	O
.	O

Propranolol	O
was	O
shown	O
to	O
reduce	O
CO2	I:C0201930
production	I:C0201930
in	O
an	O
experimental	O
DISSUB	O
model	O
in	O
humans	B:C0086418
but	O
its	O
effects	O
on	O
decompression	O
sickness	I:C0011119
in	O
a	O
DISSUB	O
rescue	O
scenario	O
are	O
unknown	O
.	O

Propranolol	O
was	O
shown	O
to	O
reduce	O
CO2	I:C0201930
production	I:C0201930
in	O
an	O
experimental	O
DISSUB	O
model	O
in	O
humans	O
but	O
its	O
effects	O
on	O
decompression	B:C0011119
sickness	I:C0011119
in	O
a	O
DISSUB	O
rescue	O
scenario	O
are	O
unknown	O
.	O

A	O
100	O
%	O
oxygen	B:C0035203
prebreathe	I:C0035203
(	O
oxygen	O
prebreathe	I:C0035203
)	O
reduces	O
decompression	O
sickness	I:C0011119
incidence	O
and	O
severity	O
and	O
is	O
incorporated	O
into	O
some	O
DISSUB	O
rescue	O
protocols	O
.	O

A	O
100	O
%	O
oxygen	O
prebreathe	I:C0035203
(	O
oxygen	B:C0035203
prebreathe	I:C0035203
)	O
reduces	O
decompression	O
sickness	I:C0011119
incidence	O
and	O
severity	O
and	O
is	O
incorporated	O
into	O
some	O
DISSUB	O
rescue	O
protocols	O
.	O

A	O
100	O
%	O
oxygen	O
prebreathe	I:C0035203
(	O
oxygen	O
prebreathe	I:C0035203
)	O
reduces	O
decompression	B:C0011119
sickness	I:C0011119
incidence	O
and	O
severity	O
and	O
is	O
incorporated	O
into	O
some	O
DISSUB	O
rescue	O
protocols	O
.	O

We	O
used	O
a	O
swine	B:C1135183
model	I:C1135183
of	O
DISSUB	O
rescue	O
to	O
study	O
the	O
effect	O
of	O
propranolol	O
on	O
decompression	O
sickness	I:C0011119
incidence	O
and	O
mortality	O
with	O
and	O
without	O
an	O
oxygen	O
prebreathe	I:C0035203
.	O

We	O
used	O
a	O
swine	O
model	I:C1135183
of	O
DISSUB	O
rescue	O
to	O
study	O
the	O
effect	O
of	O
propranolol	B:C0033497
on	O
decompression	O
sickness	I:C0011119
incidence	O
and	O
mortality	O
with	O
and	O
without	O
an	O
oxygen	O
prebreathe	I:C0035203
.	O

We	O
used	O
a	O
swine	O
model	I:C1135183
of	O
DISSUB	O
rescue	O
to	O
study	O
the	O
effect	O
of	O
propranolol	O
on	O
decompression	B:C0011119
sickness	I:C0011119
incidence	O
and	O
mortality	O
with	O
and	O
without	O
an	O
oxygen	O
prebreathe	I:C0035203
.	O

We	O
used	O
a	O
swine	O
model	I:C1135183
of	O
DISSUB	O
rescue	O
to	O
study	O
the	O
effect	O
of	O
propranolol	O
on	O
decompression	O
sickness	I:C0011119
incidence	O
and	O
mortality	O
with	O
and	O
without	O
an	O
oxygen	B:C0035203
prebreathe	I:C0035203
.	O

In	O
Experiment	O
1	O
,	O
male	O
Yorkshire	B:C0324292
Swine	I:C0324292
(	O
70	O
kg	O
)	O
were	O
pressurized	O
to	O
2.8	O
ATA	O
for	O
22	O
h.	O
Propranolol	O
1.0	O
mg	O
·	O
kg	O
-	O
1	O
(	O
IV	O
)	O
was	O
administered	O
at	O
21.25	O
h	O
.	O

In	O
Experiment	O
1	O
,	O
male	O
Yorkshire	O
Swine	I:C0324292
(	O
70	O
kg	O
)	O
were	O
pressurized	O
to	O
2.8	O
ATA	O
for	O
22	O
h.	O
Propranolol	B:C0033497
1.0	O
mg	O
·	O
kg	O
-	O
1	O
(	O
IV	O
)	O
was	O
administered	O
at	O
21.25	O
h	O
.	O

At	O
22	O
h	O
,	O
the	O
animal	B:C0003062
was	O
rapidly	O
decompressed	O
and	O
observed	O
for	O
decompression	O
sickness	I:C0011119
type	O
,	O
onset	O
time	O
,	O
and	O
mortality	O
.	O

At	O
22	O
h	O
,	O
the	O
animal	O
was	O
rapidly	O
decompressed	O
and	O
observed	O
for	O
decompression	B:C0011119
sickness	I:C0011119
type	O
,	O
onset	O
time	O
,	O
and	O
mortality	O
.	O

Experimental	O
animals	B:C0003062
(	O
N	O
=	O
21	O
;	O
69	O
±	O
4.1	O
kg	O
)	O
,	O
PROP1.0	O
,	O
were	O
compared	O
to	O
PROP1.0	O
-	O
OPB45	O
(	O
N	O
=	O
8	O
;	O
69	O
±	O
2.8	O
kg	O
)	O
with	O
the	O
same	O
dive	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
oxygen	O
prebreathe	I:C0035203
prior	O
to	O
decompression	O
.	O

Experimental	O
animals	O
(	O
N	O
=	O
21	O
;	O
69	O
±	O
4.1	O
kg	O
)	O
,	O
PROP1.0	B:C0033497
,	O
were	O
compared	O
to	O
PROP1.0	O
-	O
OPB45	O
(	O
N	O
=	O
8	O
;	O
69	O
±	O
2.8	O
kg	O
)	O
with	O
the	O
same	O
dive	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
oxygen	O
prebreathe	I:C0035203
prior	O
to	O
decompression	O
.	O

Experimental	O
animals	O
(	O
N	O
=	O
21	O
;	O
69	O
±	O
4.1	O
kg	O
)	O
,	O
PROP1.0	O
,	O
were	O
compared	O
to	O
PROP1.0	B:C0033497
-	O
OPB45	O
(	O
N	O
=	O
8	O
;	O
69	O
±	O
2.8	O
kg	O
)	O
with	O
the	O
same	O
dive	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
oxygen	O
prebreathe	I:C0035203
prior	O
to	O
decompression	O
.	O

Experimental	O
animals	O
(	O
N	O
=	O
21	O
;	O
69	O
±	O
4.1	O
kg	O
)	O
,	O
PROP1.0	O
,	O
were	O
compared	O
to	O
PROP1.0	O
-	O
OPB45	B:C0035203
(	O
N	O
=	O
8	O
;	O
69	O
±	O
2.8	O
kg	O
)	O
with	O
the	O
same	O
dive	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
oxygen	O
prebreathe	I:C0035203
prior	O
to	O
decompression	O
.	O

Experimental	O
animals	O
(	O
N	O
=	O
21	O
;	O
69	O
±	O
4.1	O
kg	O
)	O
,	O
PROP1.0	O
,	O
were	O
compared	O
to	O
PROP1.0	O
-	O
OPB45	O
(	O
N	O
=	O
8	O
;	O
69	O
±	O
2.8	O
kg	O
)	O
with	O
the	O
same	O
dive	O
profile	O
,	O
except	O
for	O
a	O
45	O
min	O
oxygen	B:C0035203
prebreathe	I:C0035203
prior	O
to	O
decompression	O
.	O

In	O
Experiment	O
2	O
,	O
the	O
same	O
methodology	O
was	O
used	O
with	O
the	O
following	O
changes	O
:	O
swine	B:C1135183
pressurized	O
to	O
2.8	O
ATA	O
for	O
28	O
h	O
;	O
experimental	O
group	O
(	O
N	O
=	O
25	O
;	O
67	O
±	O
3.3	O
kg	O
)	O
,	O
PROP0.5	O
bis	O
,	O
propranolol	O
0.5	O
mg	O
·	O
kg	O
-	O
1	O
bis	O
(	O
twice	O
)	O
(	O
IV	O
)	O
was	O
administered	O
at	O
22	O
h	O
and	O
26	O
h	O
.	O

In	O
Experiment	O
2	O
,	O
the	O
same	O
methodology	O
was	O
used	O
with	O
the	O
following	O
changes	O
:	O
swine	O
pressurized	O
to	O
2.8	O
ATA	O
for	O
28	O
h	O
;	O
experimental	O
group	O
(	O
N	O
=	O
25	O
;	O
67	O
±	O
3.3	O
kg	O
)	O
,	O
PROP0.5	B:C0033497
bis	O
,	O
propranolol	O
0.5	O
mg	O
·	O
kg	O
-	O
1	O
bis	O
(	O
twice	O
)	O
(	O
IV	O
)	O
was	O
administered	O
at	O
22	O
h	O
and	O
26	O
h	O
.	O

In	O
Experiment	O
2	O
,	O
the	O
same	O
methodology	O
was	O
used	O
with	O
the	O
following	O
changes	O
:	O
swine	O
pressurized	O
to	O
2.8	O
ATA	O
for	O
28	O
h	O
;	O
experimental	O
group	O
(	O
N	O
=	O
25	O
;	O
67	O
±	O
3.3	O
kg	O
)	O
,	O
PROP0.5	O
bis	O
,	O
propranolol	B:C0033497
0.5	O
mg	O
·	O
kg	O
-	O
1	O
bis	O
(	O
twice	O
)	O
(	O
IV	O
)	O
was	O
administered	O
at	O
22	O
h	O
and	O
26	O
h	O
.	O

Control	B:C1511501
animals	I:C1511501
(	O
N	O
=	O
25	O
;	O
67	O
±	O
3.9	O
kg	O
)	O
received	O
normal	O
saline	I:C0445115
.	O

Control	O
animals	I:C1511501
(	O
N	O
=	O
25	O
;	O
67	O
±	O
3.9	O
kg	O
)	O
received	O
normal	B:C0445115
saline	I:C0445115
.	O

oxygen	B:C0035203
prebreathe	I:C0035203
reduced	O
mortality	O
in	O
PROP1.0	O
-	O
OBP45	O
compared	O
to	O
PROP1.0	O
(	O
0	O
%	O
vs.	O
71	O
%	O
)	O
.	O

oxygen	O
prebreathe	I:C0035203
reduced	O
mortality	O
in	O
PROP1.0	B:C0033497
-	O
OBP45	O
compared	O
to	O
PROP1.0	O
(	O
0	O
%	O
vs.	O
71	O
%	O
)	O
.	O

oxygen	O
prebreathe	I:C0035203
reduced	O
mortality	O
in	O
PROP1.0	O
-	O
OBP45	B:C0035203
compared	O
to	O
PROP1.0	O
(	O
0	O
%	O
vs.	O
71	O
%	O
)	O
.	O

oxygen	O
prebreathe	I:C0035203
reduced	O
mortality	O
in	O
PROP1.0	O
-	O
OBP45	O
compared	O
to	O
PROP1.0	B:C0033497
(	O
0	O
%	O
vs.	O
71	O
%	O
)	O
.	O

PROP0.5	B:C0033497
bis	O
had	O
increased	O
mortality	O
compared	O
to	O
CONTROL	O
(	O
60	O
-	O
%	O
vs.	O
4	O
%	O
)	O
.	O

Administration	O
of	O
beta	B:C0001645
blockers	I:C0001645
prior	O
to	O
saturation	O
decompression	O
appears	O
to	O
increase	O
decompression	O
sickness	I:C0011119
and	O
worsen	O
mortality	O
in	O
a	O
swine	O
model	O
;	O
however	O
,	O
their	O
effects	O
in	O
bounce	O
diving	O
remain	O
unknown	O
.	O

Administration	O
of	O
beta	O
blockers	I:C0001645
prior	O
to	O
saturation	O
decompression	O
appears	O
to	O
increase	O
decompression	B:C0011119
sickness	I:C0011119
and	O
worsen	O
mortality	O
in	O
a	O
swine	O
model	O
;	O
however	O
,	O
their	O
effects	O
in	O
bounce	O
diving	O
remain	O
unknown	O
.	O

Administration	O
of	O
beta	O
blockers	I:C0001645
prior	O
to	O
saturation	O
decompression	O
appears	O
to	O
increase	O
decompression	O
sickness	I:C0011119
and	O
worsen	O
mortality	O
in	O
a	O
swine	B:C1135183
model	O
;	O
however	O
,	O
their	O
effects	O
in	O
bounce	O
diving	O
remain	O
unknown	O
.	O

